ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
2.820
-0.140 (-4.73%)
At close: Nov 4, 2025, 4:00 PM EST
2.860
+0.040 (1.42%)
After-hours: Nov 4, 2025, 6:12 PM EST
ABVC BioPharma Stock Forecast
Stock Price Forecast
There have not been any analyst price target forecasts for ABVC BioPharma in the last 12 months.
Price Target: n/a
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for ABVC BioPharma.
Recommendation Trends
| Rating | Nov '22 |
|---|---|
| Strong Buy | 0 |
| Buy | 0 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 16, 2022 |
Financial Forecast
Revenue This Year
4.26M
from 509.59K
Increased by 735.18%
Revenue Next Year
n/a
from 4.26M
EPS This Year
-0.47
from -0.42
EPS Next Year
n/a
from -0.47
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 |
|---|---|
| High | 4.4M |
| Avg | 4.3M |
| Low | 4.1M |
Revenue Growth
| Revenue Growth | 2025 |
|---|---|
| High | 759.9% |
| Avg | 735.2% |
| Low | 702.6% |
EPS Forecast
| EPS | 2025 |
|---|---|
| High | -0.48 |
| Avg | -0.47 |
| Low | -0.45 |
EPS Growth
| EPS Growth | 2025 |
|---|---|
| High | - |
| Avg | - |
| Low | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.